Fortune

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmineWorldPing

Pattern hair loss affects an estimated 50 million men and 30 million women in the US, but there have been no new approved drugs since the late 1990s.

This is a short WorldPing brief. The full report was published by Fortune.

Read the full report at Fortune

Related news